Matches in SemOpenAlex for { <https://semopenalex.org/work/W4237597660> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W4237597660 endingPage "S310" @default.
- W4237597660 startingPage "S310" @default.
- W4237597660 abstract "Abstract Background Ceftazidime–avibactam (CAZ-AVI) is a β-lactam/non-β-lactam β-lactamase inhibitor combination that can inhibit class A, C and some class D β-lactamases but not class B metallo-β-lactamases (MBLs). Antimicrobial resistance due to these β-lactamases and other mechanisms is increasing and is especially high in ICUs. This study evaluated the in vitro activity of CAZ-AVI and comparators against Pseudomonas aeruginosa isolates from patients in ICU and non-ICU wards. Methods Nonduplicate clinical isolates were collected in 2016–2017 in Asia/Pacific, Europe, Latin America, and Middle East/Africa. Susceptibility testing was performed using CLSI broth microdilution and interpreted using CLSI 2019 breakpoints. PCR and sequencing were used to determine the β-lactamase genes present in all isolates with meropenem (MEM) MIC >2 µg/mL. Results The activity of CAZ-AVI and comparators is shown in the table. Susceptibility rates among global P. aeruginosa were generally lower for isolates from patients in ICU than non-ICU wards, but this difference was small for CAZ-AVI (89% and 92% susceptible, respectively) and for amikacin and colistin. Among MEM-nonsusceptible (NS) isolates, CAZ-AVI was active against 72% and 70% of isolates, respectively, of which 18.4% and 18.7% were MBL-positive. CAZ AVI inhibited >83% of MEM-NS MBL-negative isolates globally. In Latin America (LA), CAZ-AVI was active against 87% of isolates from both ward types. Susceptibility rates were generally lower than the global average, especially among MEM-NS isolates and isolates from non-ICU wards. The proportion of MBL-positive isolates in the MEM-NS subset was only slightly higher in LA than globally (19.2% and 19.5% in ICU and non-ICU wards, respectively), suggesting the presence of additional resistance mechanisms. Only colistin exceeded the activity of CAZ-AVI against isolates collected globally and in LA. Conclusion CAZ-AVI showed potent antimicrobial activity, second only to that of colistin, against P. aeruginosa isolates from both ICU and non-ICU wards, with >88% of isolates collected globally testing as susceptible. Activity was in part compromised by MBLs, although additional resistance mechanisms may also be responsible. Disclosures All authors: No reported disclosures." @default.
- W4237597660 created "2022-05-12" @default.
- W4237597660 creator A5017159626 @default.
- W4237597660 creator A5020992600 @default.
- W4237597660 creator A5038009031 @default.
- W4237597660 creator A5066677972 @default.
- W4237597660 date "2019-10-01" @default.
- W4237597660 modified "2023-10-18" @default.
- W4237597660 title "680. In vitro Activity of Ceftazidime–Avibactam and Comparator Agents Against Pseudomonas aeruginosa from ICU and Non-ICU Wards Collected in Latin America and Globally as Part of the ATLAS Surveillance Program 2016–2017" @default.
- W4237597660 doi "https://doi.org/10.1093/ofid/ofz360.748" @default.
- W4237597660 hasPublicationYear "2019" @default.
- W4237597660 type Work @default.
- W4237597660 citedByCount "1" @default.
- W4237597660 countsByYear W42375976602021 @default.
- W4237597660 crossrefType "journal-article" @default.
- W4237597660 hasAuthorship W4237597660A5017159626 @default.
- W4237597660 hasAuthorship W4237597660A5020992600 @default.
- W4237597660 hasAuthorship W4237597660A5038009031 @default.
- W4237597660 hasAuthorship W4237597660A5066677972 @default.
- W4237597660 hasBestOaLocation W42375976601 @default.
- W4237597660 hasConcept C176947019 @default.
- W4237597660 hasConcept C2775933652 @default.
- W4237597660 hasConcept C2776968632 @default.
- W4237597660 hasConcept C2777406300 @default.
- W4237597660 hasConcept C2777427914 @default.
- W4237597660 hasConcept C2777637488 @default.
- W4237597660 hasConcept C2779259085 @default.
- W4237597660 hasConcept C2779375183 @default.
- W4237597660 hasConcept C2780950330 @default.
- W4237597660 hasConcept C4937899 @default.
- W4237597660 hasConcept C501593827 @default.
- W4237597660 hasConcept C523546767 @default.
- W4237597660 hasConcept C54355233 @default.
- W4237597660 hasConcept C71924100 @default.
- W4237597660 hasConcept C86803240 @default.
- W4237597660 hasConcept C89423630 @default.
- W4237597660 hasConcept C94665300 @default.
- W4237597660 hasConceptScore W4237597660C176947019 @default.
- W4237597660 hasConceptScore W4237597660C2775933652 @default.
- W4237597660 hasConceptScore W4237597660C2776968632 @default.
- W4237597660 hasConceptScore W4237597660C2777406300 @default.
- W4237597660 hasConceptScore W4237597660C2777427914 @default.
- W4237597660 hasConceptScore W4237597660C2777637488 @default.
- W4237597660 hasConceptScore W4237597660C2779259085 @default.
- W4237597660 hasConceptScore W4237597660C2779375183 @default.
- W4237597660 hasConceptScore W4237597660C2780950330 @default.
- W4237597660 hasConceptScore W4237597660C4937899 @default.
- W4237597660 hasConceptScore W4237597660C501593827 @default.
- W4237597660 hasConceptScore W4237597660C523546767 @default.
- W4237597660 hasConceptScore W4237597660C54355233 @default.
- W4237597660 hasConceptScore W4237597660C71924100 @default.
- W4237597660 hasConceptScore W4237597660C86803240 @default.
- W4237597660 hasConceptScore W4237597660C89423630 @default.
- W4237597660 hasConceptScore W4237597660C94665300 @default.
- W4237597660 hasIssue "Supplement_2" @default.
- W4237597660 hasLocation W42375976601 @default.
- W4237597660 hasLocation W42375976602 @default.
- W4237597660 hasOpenAccess W4237597660 @default.
- W4237597660 hasPrimaryLocation W42375976601 @default.
- W4237597660 hasRelatedWork W2408072278 @default.
- W4237597660 hasRelatedWork W2557234235 @default.
- W4237597660 hasRelatedWork W2569300957 @default.
- W4237597660 hasRelatedWork W2944613386 @default.
- W4237597660 hasRelatedWork W2990287059 @default.
- W4237597660 hasRelatedWork W3119311612 @default.
- W4237597660 hasRelatedWork W3119336834 @default.
- W4237597660 hasRelatedWork W3176249812 @default.
- W4237597660 hasRelatedWork W4237597660 @default.
- W4237597660 hasRelatedWork W4281249697 @default.
- W4237597660 hasVolume "6" @default.
- W4237597660 isParatext "false" @default.
- W4237597660 isRetracted "false" @default.
- W4237597660 workType "article" @default.